Respiratory

Back to articles

Use of eszopiclone improves CPAP adherence

KEY POINT

Data from a 6-month study in 160 adult patients with newly diagnosed severe obstructive sleep apnea show that giving eszopiclone (Lunesta—Sepracor) for the first 14 nights of continuous positive airway pressure (CPAP) improves adherence to therapy compared with placebo.